Advances in pancreatic cancer research from 2017 annual meeting of the American Society of Clinical Oncology
10.3760/cma.j.issn.1673-9752.2017.07.009
- VernacularTitle:2017年美国临床肿瘤学会年会胰腺癌研究进展解析
- Author:
Qi CHEN
;
Tao WEI
;
Yiwen CHEN
;
Jianxin WANG
;
Xueli BAI
;
Tingbo LIANG
- Keywords:
Pancreatic neoplasms;
Chemotherapy;
Immunotherapy;
Targeted therapy;
Neoadjuvant therapy
- From:
Chinese Journal of Digestive Surgery
2017;16(7):684-688
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is one of the most aggres sive malignant tumors with dismal prognosis.The 2017 annualmeeting of the American Society of Clinical Oncology (ASCO)brings together thousands of oncology professionals from around the world to discuss state-of-the-art treatment modalities,new therapies,and ongoing controversies in the field.In this paper,authors selected and reviewed pancreatic cancer research from 2017 annual meeting of the ASCO,especially the latest research progress in genetic diagnosis,chemotherapy,immunotherapy,targeted therapy and neoadjuvant treatments.